Haleon PLC Sponsored ADR (HLN) has released an update.
Haleon PLC has announced the cancellation of 102,272,727 ordinary shares previously repurchased from Pfizer Inc., leaving the company with a total of 9,132,301,104 ordinary shares with voting rights as of March 21, 2024. This cancellation could affect shareholders and their notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. Haleon is recognized as a global leader in consumer health, with popular brands such as Advil and Sensodyne among its diverse product portfolio.
For further insights into HLN stock, check out TipRanks’ Stock Analysis page.
